Note: Revenues for privately held companies are statistical evaluations.
Astrazeneca Pharmaceuticals's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.
Note: Astrazeneca Pharmaceuticals's revenues are gauged from an analysis of company filings.
Astrazeneca Pharmaceuticals's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Astrazeneca Pharmaceuticals Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Astrazeneca Pharmaceuticals is developing and marketing.
Astrazeneca Pharmaceuticals doesn't have any recent trademark applications, indicating Astrazeneca Pharmaceuticals is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
BCISE Pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders
04/01/2015
ATHEROVIEW Spectrometers
02/12/2008
VASORISK Spectrometers
02/12/2008
See all trademarks and details in the Full Report.
Recession Risk
Determine whether Astrazeneca Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Astrazeneca Pharmaceuticals is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Astrazeneca Pharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Astrazeneca Pharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Astrazeneca Pharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Astrazeneca Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.